We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Survival rates following transplantation did not differ ...
University of South Florida pulmonologist Dr. Jose Herazo-Maya has focused his career on researching treatments for pulmonary fibrosis, a devastating and deadly lung disease. Pulmonary fibrosis in ...
Researchers have uncovered changes in the cellular response throughout lung damage caused by SARS-CoV-2—the virus behind COVID-19. The team revealed distinct phases where waves of immune responses ...
The COVID-19 pandemic engulfed the U.S. five years ago this month, leaving not only lingering mental health effects but also long-term physical symptoms. One of those included a condition known as ...
Please provide your email address to receive an email when new articles are posted on . With advanced X-rays and blood biomarkers, researchers have found how lung tissue scarring in patients with ...
Long COVID occurs in approximately a third of COVID-19 survivors, with the CDC estimating one in 13 adults in the United States have long COVID symptoms such as brain fog, shortness of breath and ...
In a recent study published in PNAS, researchers elucidated immunologic and genetic perturbations in long coronavirus disease (COVID) patients with pulmonary fibrosis. In the present study, ...
A study conducted in Brazil points to long-term functional abnormalities in their lungs two years after hospital discharge in most severe COVID-19 patients who had required intubation, and a return of ...
Researchers discover that glycogen and N-linked glycans accumulate in fibrotic regions of the lung and may be important for therapy development. Ramon Sun, a biochemist at the University of Florida ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results